Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05922722 · ClinicalTrials.gov registry record
Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 200
- Enrollment target
NCT05922722: Completed study, sponsored by University of Wisconsin, Madison.
NCT05922722 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05922722 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect information from lupus patients about their experience with a tool that informs patients about the benefits vs. harms of a medication such as hydroxychloroquine. The main question it aims to answer is whether the decision-making tool will increase medication adherence. Participants will be asked to complete questionnaires that assess their understanding of the decision-making tool.
Primary Outcome
Compare mean adherence at baseline and three months after completing the intervention. Mean adherence will be measured using the proportion of days covered (PDC). PDC is calculated using prescription refill data (PDC = Sum of days covered/number of days in the observation period)
Interventions
- OTHER Questionnaire
- OTHER Decision-making tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2025-02-20 |
What the finished NCT05922722 record still lists
NCT05922722 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT05922722 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05922722 about?
NCT05922722 is a clinical study titled "Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus". The purpose of this research study is to collect information from lupus patients about their experience with a tool that informs patients about the benefits vs. harms of a medication such as hydroxychloroquine. The main question it aims to answer is whether the decision-making tool will increase med...
What is the current status of trial NCT05922722?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2024-02-15. Estimated completion is 2025-02-20.
What interventions are being tested in trial NCT05922722?
The interventions under investigation include: Questionnaire (OTHER), Decision-making tool (OTHER).
Who is sponsoring clinical trial NCT05922722?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI